Safety and Effectiveness of Four-Factor Prothrombin Complex Concentrate in Special Populations with INR Below 2: A Post-Marketing Surveillance Study
Autor: | Masahiro Yasaka, Fumihiko Shimizu, Yuki Niwa, Ayako Kiyonaga, Naoki Terasaka |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Cardiology and Therapy, Vol 13, Iss 3, Pp 603-614 (2024) |
Druh dokumentu: | article |
ISSN: | 2193-8261 2193-6544 |
DOI: | 10.1007/s40119-024-00380-7 |
Popis: | Abstract Introduction We previously conducted a prospective, observational post-marketing surveillance study to assess the safety and effectiveness of four-factor prothrombin complex concentrate (4F-PCC) for rapid vitamin K antagonist (VKA) reversal in Japanese patients. Methods This subgroup analysis compared the safety, especially thromboembolic events (TEEs), and effectiveness of 4F-PCC by stratifying patients into two subgroups according to baseline international normalized ratio (INR) levels with |
Databáze: | Directory of Open Access Journals |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |